151 related articles for article (PubMed ID: 11091773)
1. Measuring medication adherence: are missed doses reported more accurately then perfect adherence?
Wagner GJ; Rabkin JG
AIDS Care; 2000 Aug; 12(4):405-8. PubMed ID: 11091773
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with accurate self-reported adherence to HIV antiretrovirals.
Kimmerling M; Wagner G; Ghosh-Dastidar B
Int J STD AIDS; 2003 Apr; 14(4):281-4. PubMed ID: 12716500
[TBL] [Abstract][Full Text] [Related]
3. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
Barfod TS; Sørensen HT; Nielsen H; Rodkjaer L; Obel N
HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
[TBL] [Abstract][Full Text] [Related]
4. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
[TBL] [Abstract][Full Text] [Related]
5. Medication adherence in patients with HIV infection: a comparison of two measurement methods.
Melbourne KM; Geletko SM; Brown SL; Willey-Lessne C; Chase S; Fisher A
AIDS Read; 1999 Aug; 9(5):329-38. PubMed ID: 12737122
[TBL] [Abstract][Full Text] [Related]
6. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
Fairley CK; Permana A; Read TR
HIV Med; 2005 Sep; 6(5):366-9. PubMed ID: 16156886
[TBL] [Abstract][Full Text] [Related]
7. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients.
Glass TR; De Geest S; Hirschel B; Battegay M; Furrer H; Covassini M; Vernazza PL; Bernasconi E; Rickenboch M; Weber R; Bucher HC;
Antivir Ther; 2008; 13(1):77-85. PubMed ID: 18389901
[TBL] [Abstract][Full Text] [Related]
8. A randomized comparison of two instruments for measuring self-reported antiretroviral adherence.
Mannheimer S; Thackeray L; Huppler Hullsiek K; Chesney M; Gardner EM; Wu AW; Telzak EE; Lawrence J; Baxter J; Friedland G;
AIDS Care; 2008 Feb; 20(2):161-9. PubMed ID: 18293124
[TBL] [Abstract][Full Text] [Related]
9. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
[TBL] [Abstract][Full Text] [Related]
10. How late is too late? Timeliness to scheduled visits as an antiretroviral therapy adherence measure in Nairobi, Kenya and Lusaka, Zambia.
Blacher RJ; Muiruri P; Njobvu L; Mutsotso W; Potter D; Ong'ech J; Mwai P; Degroot A; Zulu I; Bolu O; Stringer J; Kiarie J; Weidle PJ
AIDS Care; 2010 Nov; 22(11):1323-31. PubMed ID: 20711886
[TBL] [Abstract][Full Text] [Related]
11. Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy.
Sullivan PS; Campsmith ML; Nakamura GV; Begley EB; Schulden J; Nakashima AK
PLoS One; 2007 Jun; 2(6):e552. PubMed ID: 17579723
[TBL] [Abstract][Full Text] [Related]
12. Validity of a stage of change instrument in assessing medication adherence in indigent patients with HIV infection.
Rathbun RC; Farmer KC; Lockhart SM; Stephens JR
Ann Pharmacother; 2007 Feb; 41(2):208-14. PubMed ID: 17213294
[TBL] [Abstract][Full Text] [Related]
13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
14. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
Cruess DG; Minor S; Antoni MH; Millon T
J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
[TBL] [Abstract][Full Text] [Related]
15. Measuring HIV treatment adherence in clinical practice.
Hecht FM
AIDS Clin Care; 1998 Aug; 10(8):57-9. PubMed ID: 11365682
[TBL] [Abstract][Full Text] [Related]
16. Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report.
Bruce JM; Hancock LM; Lynch SG
Mult Scler; 2010 Jan; 16(1):112-20. PubMed ID: 19995835
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
[TBL] [Abstract][Full Text] [Related]
18. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
Diabaté S; Alary M; Koffi CK
AIDS; 2007 Aug; 21(13):1799-803. PubMed ID: 17690579
[TBL] [Abstract][Full Text] [Related]
19. Literacy, self-efficacy, and HIV medication adherence.
Wolf MS; Davis TC; Osborn CY; Skripkauskas S; Bennett CL; Makoul G
Patient Educ Couns; 2007 Feb; 65(2):253-60. PubMed ID: 17118617
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia.
Tadios Y; Davey G
Ethiop Med J; 2006 Jul; 44(3):237-44. PubMed ID: 17447389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
